The programme is designed to combine high calibre lectures and interactive discussions to provide an educational opportunity to update clinicians and allied professions in current issues within the management of diseases affecting haematology patients.


  • CLL
  • Relapsed CLL: Have the new therapies completely replaced chemotherapy?
  • AML
  • Evolution in the management of AML
  • ALL
  • MRD and blinatumomab
  • MRD relevance pre and post-transplant
  • Workshop in Myeloma
  • Upfront treatments
  • Relapse in myeloma
  • Patient-based discussion
  • MDS
  • New treatments and iron chelation
  • Infectious Diseases in Haematology
  • Hepatitis & TB
  • Lymphoma MDT – Carousel of Cases
  • Adolescent TYA and chemotherapy – OEPA/COPDac versus ABVD
  • Improving RCHOP? Update on trials in progress
  • Combined modality treatment in early Hodgkin lymphoma
  • Refractory late Hodgkin lymphoma
  • Hodgkin lymphoma – H10 vs RAPID vs HD12/16
  • Chemo free in follicular lymphoma
  • Treating an 84 year old – assessment factors
  • How to get patients to CAR T cell therapy – what’s happening in your region?


  • Consultants 
  • Trainees 
  • Nurses 
  • Pharmacists
  • Scientists working in haematology


  • Professor Graham Jackson, NCCC Newcastle
  • Dr Ceri Bygrave University Hospital of Wales, Cardiff
  •  Dr Hannah Hunter University Hospitals Plymouth
  • Professor Chris Fegan University Hospital of Wales
  • Professor David Marks University Hospitals Bristol
  • Dr Steve Knapper University Hospital of Wales
  • Dr Anne Parker Queen Elizabeth University Hospital, Glasgow
  • Dr Jonathan Kell University Hospital of Wales
  • Dr Andrew McMillan Nottingham University Hospitals
  • Dr Steve Robinson University Hospitals Bristol
  • Professor Tim Illidge Christie Hospital Manchester
  • Dr Wendy Osborne NCCC Newcastle

For more information, please contact Chloe Irlam:

  • 10:00 - 21/11/2019 to 17:00 - 21/11/2019
  • DoubleTree by Hilton Hotel, Redcliffe Way, Bristol , BS1 6NJ, United Kingdom (Great Britain)